Intracellular tumor microenvironment

The intracellular tumor microenvironment (ITME) encompasses the distinct biochemical and physiological conditions found within a malignant cell, including altered redox potential, acidic organelle pH, and specific enzymatic profiles (Nature Reviews Cancer, 2021). Unlike the extracellular tumor microenvironment, which consists of the surrounding stroma and immune cells, the ITME focuses on the internal state of the cancer cell itself (NCI, 2023). It is characterized by significantly higher concentrations of reducing agents like glutathione (GSH) and elevated levels of reactive oxygen species (ROS) compared to healthy cells (Journal of Controlled Release, 2022). These unique conditions are frequently exploited in the development of stimuli-responsive nanomedicines and antibody-drug conjugates (ADCs) designed to release their therapeutic payload only upon entering the tumor cell (Advanced Drug Delivery Reviews, 2020). This approach aims to maximize the therapeutic index of cytotoxic drugs while minimizing systemic side effects. However, the ITME is highly heterogeneous, varying significantly between different cancer types and even within different regions of the same tumor, which poses a major challenge for the clinical translation of environment-responsive therapies (Trends in Pharmacological Sciences, 2019).

Other names

Tumor cell intracellular environmentCancer cell internal milieuIntracellular TME

Stimuli-responsive release of therapeutic agents triggered by intracellular biochemical cues such as high glutathione concentration, acidic pH, or specific enzyme activity.